This public procurement record has 1 release in its history.

Planning

11 Nov 2026 at 12:24

Summary of the contracting process

Birmingham Women’s and Children’s NHS Foundation Trust is reviewing how to manage equipment, consumables and related support for its Genetics Laboratory. The potential scope includes laboratory equipment procurement, servicing and maintenance, consumables purchasing, inventory and stock management, asset replacement and associated support services. The Trust is considering whether a managed equipment service could bring these functions together, while retaining clinical, scientific and regulatory oversight. The work relates to specialist medical services for genomic testing, delivered for the Genetics Laboratory in Birmingham. The review responds to growing complexity and scale in genomic technologies and a large, diverse equipment estate. University Hospitals Birmingham NHS Foundation Trust’s procurement team is managing the process on the Trust’s behalf.

This is at the planning stage: the buyer is conducting preliminary market engagement to help define the future requirements, scope, commercial structure and delivery model. No invitation to tender has been issued. The buyer expects to publish a subsequent notice on 1 February 2027. The engagement milestone is scheduled for 2 December 2026; this is a planning date, not a bid deadline. The current baseline expenditure across laboratory assets, consumables and support is around £12 million annually. The estimated procurement value is currently recorded as £0 because the future scope and commercial model remain undefined. One lot is planned, with an indicative contract period from 1 July 2027 to 30 June 2034. The procedure, award criteria and supplier eligibility requirements have not yet been settled in the planning information.

This review is relevant to suppliers able to provide an integrated managed equipment service for a specialist genetics laboratory, rather than only supplying individual items. Potentially well-placed businesses include providers combining laboratory equipment sourcing and lifecycle management with maintenance, consumables supply, inventory control and asset replacement planning. The buyer has identified a need to improve operational resilience, standardisation and long-term sustainability, manage a growing portfolio of service contracts, and reduce the burden of non-core operational work on laboratory staff. Suppliers should be prepared to explain how their model can support growth in genomic testing, continuity of laboratory operations and regulatory compliance while preserving the Trust’s clinical, scientific and regulatory oversight. The scale and diversity of the equipment estate and the range of linked services make this a substantial, multi-capability requirement.

How relevant is this notice?

Notice Information

Notice Title

BWC Genetic Laboratory Managed Equipment Service PME

Notice Description

The Genetics Laboratory currently manages equipment procurement, maintenance arrangements, consumable purchasing, inventory management and asset replacement through a combination of scientific, technical, procurement and support staff. While this model has successfully supported significant growth in genomic testing activity, a number of opportunities have been identified to improve resilience, standardisation and long-term sustainability. Specific challenges identified include: * Increasing complexity and scale of genomic technologies. * Managing a growing portfolio of equipment service and maintenance contracts. * Requirement for more sophisticated inventory and stock management solutions. * Need for improved resilience and continuity arrangements. * Pressure on laboratory staff to undertake non-core operational activities. * Requirement to maintain regulatory compliance whilst supporting service growth. * Long-term capital replacement planning across a large and diverse equipment estate. BWC is therefore exploring whether a Managed Equipment Service model could provide operational, financial and strategic benefits whilst maintaining full clinical, scientific and regulatory oversight The contracting authority is undertaking a strategic review of its future operating models for laboratory assets, consumables, and associated support services. The current baseline expenditure across these categories is around PS12 million annually. The estimated procurement value is currently set at PS0 as the future scope, commercial structure, and delivery models are completely undefined. This UK2 notice is an invitation for preliminary market engagement to help shape our future requirements.

Planning Information

The Genetics Laboratory currently manages equipment procurement, maintenance arrangements, consumable purchasing, inventory management and asset replacement through a combination of scientific, technical, procurement and support staff. While this model has successfully supported significant growth in genomic testing activity, a number of opportunities have been identified to improve resilience, standardisation and long-term sustainability. Specific challenges identified include: • Increasing complexity and scale of genomic technologies. • Managing a growing portfolio of equipment service and maintenance contracts. • Requirement for more sophisticated inventory and stock management solutions. • Need for improved resilience and continuity arrangements. • Pressure on laboratory staff to undertake non-core operational activities. • Requirement to maintain regulatory compliance whilst supporting service growth. • Long-term capital replacement planning across a large and diverse equipment estate. BWC is therefore exploring whether a Managed Equipment Service model could provide operational, financial and strategic benefits whilst maintaining full clinical, scientific and regulatory oversight The contracting authority is undertaking a strategic review of its future operating models for laboratory assets, consumables, and associated support services. The current baseline expenditure across these categories is around £12 million annually. The estimated procurement value is currently set at £0 as the future scope, commercial structure, and delivery models are completely undefined. This UK2 notice is an invitation for preliminary market engagement to help shape our future requirements.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07b984
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/107076-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85121200 - Medical specialist services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
11 Nov 20265 days ago
Submission Deadline
Not specified
Future Notice Date
1 Feb 20273 months to go
Award Date
Not specified
Contract Period
1 Jul 2027 - 30 Jun 2034 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Birmingham Women's and Children's NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BIRMINGHAM
Postcode
B4 6NH
Postcode Area
Birmingham
Country
England

Major Region (ITL 1)
TLG West Midlands (England)
Basic Region (ITL 2)
TLG3 West Midlands
Small Region (ITL 3)
TLG31 Birmingham
Delivery Location
TLG31 Birmingham

Local Authority
Birmingham
Electoral Ward
Ladywood
Westminster Constituency
Birmingham Ladywood

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...